Aclarion, a healthcare technology company, announced the appointment of Greg Gould as Chief Financial Officer.
Greg Gould brings over 30 years of experience in public and private companies, focusing on growth and value creation.
His expertise includes capital raising, profitability driving, and scaling operations to $500M revenue.
Extensive Experience
Greg Gould has raised over $450 million in public company debt and equity offerings.
Strategic Leadership
He has led over ten acquisitions and successfully guided three organizations through uplistings to Nasdaq.
Public Company CFO Roles
Greg has served as CFO in 7 publicly-traded companies, including Charlotte's Web and Aytu BioScience.
Innovative Technology
Aclarion's Nociscan platform helps physicians identify the location of chronic low back pain noninvasively.
- Chronic low back pain affects approximately 266 million people globally, and Nociscan aims to improve surgical outcomes with quantifiable biomarkers.
- Greg Gould's appointment strengthens Aclarion's financial leadership and strategic direction for long-term value creation.
Greg Gould's appointment as CFO positions Aclarion for continued growth and innovation in the healthcare technology sector.